IP Verse

Nutritional Compositions Comprising Human Milk Oligosaccharides And Nucleotides And Uses Thereof For Treating And/Or Preventing Enteric Viral Infection - EP2658399

The patent EP2658399 was granted to Abbott on Feb 28, 2024. The application was originally filed on Dec 22, 2011 under application number EP11809048A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2658399

ABBOTT
Application Number
EP11809048A
Filing Date
Dec 22, 2011
Status
Patent Maintained As Amended
Jan 26, 2024
Publication Date
Feb 28, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

NUTRICIANov 27, 2019NEDERLANDSCH OCTROOIBUREAUWITHDRAWN
NESTLENov 26, 2019KRISHNANDEEMED NOT TO HAVE BEEN FILED

Patent Citations (25) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2003118703
DESCRIPTIONUS2009098240
DESCRIPTIONUS6306908
DESCRIPTIONUS6365218
DESCRIPTIONUS6589576
INTERNATIONAL-SEARCH-REPORTEP1634599
INTERNATIONAL-SEARCH-REPORTWO0142263
INTERNATIONAL-SEARCH-REPORTWO2007114683
INTERNATIONAL-SEARCH-REPORTWO2011090926
INTERNATIONAL-SEARCH-REPORTWO2011136636
OPPOSITIONUS2010233129
OPPOSITIONUS5492899
OPPOSITIONWO2004002495
OPPOSITIONWO2004093885
OPPOSITIONWO2005055944
OPPOSITIONWO2006019300
OPPOSITIONWO2009059996
OPPOSITIONWO2009082216
OPPOSITIONWO2010092153
OPPOSITIONWO2011008087
OTHERWO2004002495
OTHERWO2005055944
OTHERWO2006019300
OTHERWO2009059996
OTHERWO2009082216

Non-Patent Literature (NPL) Citations (20) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
EXAMINATION- BRUNSER O ET AL, "Effect of dietary nucleotide supplementation on diarrhoeal disease in infants", ACTA PAEDIATRICA, (1994), vol. 83, no. 2, ISSN 0803-5253, pages 188 - 191, XP055489847
EXAMINATION- DAVID S NEWBURG ET AL, "Human milk glycans protect infants against enteric pathogens", ANNUAL REVIEW OF NUTRITION, ANNUAL REVIEWS INC., PALO ALTO, CA, US, vol. 25, doi:10.1146/ANNUREV.NUTR.25.050304.092553, ISSN 0199-9885, (20050701), pages 37 - 58,C, (20050503), XP002640519
OPPOSITION- BOZA et al., "Role and function of nucleotides in infant nutrition", Infant formula: closer to the reference, Philadelphia, (20020000), vol. 47, pages 165 - 184, XP055660323
OPPOSITION- Commission Directive 2006/141/ec of 22.12.2006
OPPOSITION- HEINE et al., "Sialic acid in breast milk and infant formula", Monatsschr Kinderheikd, (19930000), vol. 141, no. 12, pages 946 - 950, XP008064948
OPPOSITION- OCHONICKY et al., "Inhibitory effects of human and porcine milk oligosaccharides on sialic acid dependent and sialic acid independent strains of rotavirus", J.Anim. Sci., (20050000), vol. 83, pages 365 - 366
OPPOSITION- P. lsa et.al., Glycoconj J (2006), 23: 27-37
OPPOSITION- YOLKEN et al., "Sialic acid glycoproteins inhibit in vitro and in vivo replication of rotaviruses", J. Clin. Invest., (19870000), vol. 79, doi:10.1172/JCI112775, pages 148 - 154, XP008163487
OPPOSITION- ISA et al., "Role of sialic acids in rotavirus infection", Glycoconj J, (20060000), vol. 23, doi:10.1007/s10719-006-5435-y, pages 27 - 37, XP019207073
OPPOSITION- ISA et al., "Role of sialic acids in rotavirus infection", Glycoconj J, (20060000), vol. 23, pages 27 - 37, XP019207073
OPPOSITION- NERI-ALMEIDA et al., "Lack of effect of nucleotide-supplemented infant formula on the management of acute diarrhea in infants", Nutrition Research, (20090000), vol. 29, doi:10.1016/j.nutres.2009.03.004, pages 244 - 247, XP026089030
OPPOSITION- HESTER et al., "Human milk oligosaccharides inhibit rotavirus infectivity in vitro and in acutely infected piglet s .", British Journal of Nutrition, (20130000), vol. 110, doi:10.1017/S0007114513000391, pages 1233 - 1242, XP055166726
OPPOSITION- WANG et al., "The role and potential of sialic acid in human nutrition", European Journal of clinical nutrition, (20030000), vol. 57, pages 1351 - 1369, XP055660316
OPPOSITION- KUCHAN et al., "Influence of purine intake on uric acid excretion in infants fed soy infant formulas", Journal of the American college of Nutrition, (20000000), vol. 19, no. 81, pages 16 - 22, XP055660320
OPPOSITION- OSTROM et al., "Immune status of infants fed soy-based formulas with or without added nucleotides for 1 year: part 1: vaccine responses and morbidity", Journal of Pediatric Gastroenterology and Nutrition, (20020000), vol. 34, pages 137 - 144, XP055660312
OPPOSITION- YAU et al., "Effect of nucleotides on diarrhea and immune responses in healthy term infants in Taiwan", Journal of pediatric gastroenterology and nutrition, (20030000), vol. 36, pages 37 - 43, XP055660325
OPPOSITION- BRUNSER et al., "Effect of dietary nucleotide supplementation on diarrhoeal disease in infants", Acta Paediatr, (19940000), vol. 83, pages 189 - 191, XP055489847
OPPOSITION- YOLKEN et al., "Human milk mucin inhibits rotavirus replication and prevents experimental gastroenteritis", J, Clin. Invest., (19920000), vol. 90, pages 1984 - 1991, XP009168276
OPPOSITION- ESPINOZA et al., "Nucleotide-enriched milk and diarrheal disease in infants", Pediatric Research, (19920000), vol. 32, page 739, XP055660310
OPPOSITION- DUFFY et al., "The Effects of infant feeding on rotavirus-induced gastroenteritis: A prospective study", American journal of public health, (19860000), vol. 76, no. 3, pages 259 - 263, XP055660313

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents